Fischell Department of Bioengineering, University of Maryland, 3234 Jeong Kim Engineering Building, College Park, Maryland, 20742, USA.
Program in Molecular and Cellular Biology, University of Maryland, College Park, Maryland, USA.
AAPS J. 2017 Nov 27;20(1):1. doi: 10.1208/s12248-017-0160-y.
Recently, extracellular vesicles (EVs)-including exosomes, microvesicles, and others-have attracted interest as cell-derived biotherapeutics and drug delivery vehicles for a variety of applications. This interest stems from favorable properties of EVs, including their status as mediators of cell-cell communication via transfer of biological cargo and their reported ability to cross biological barriers that impede many delivery systems. However, there are many challenges to translation and widespread application of EV-based therapeutics. One such challenge that has yet to be extensively studied involves EV preservation and storage, which must be addressed to enable use of therapeutic EVs beyond resource-intensive settings. Studies to date suggest that the most promising mode of storage is - 80°C; however, understanding of storage-mediated effects is still limited. Additionally, the effects of storage appear to vary with sample source. The lack of knowledge about and standardization of EV storage may ultimately hinder widespread clinical translation. This mini-review reports current knowledge in the field of EV preservation and storage stability and highlights future directions in the area that could be critical to eventual development of EV therapies.
最近,细胞外囊泡(EVs)——包括外泌体、微囊泡等——作为细胞来源的生物治疗剂和药物递送载体引起了人们的兴趣,可用于多种应用。这种兴趣源于 EVs 的有利特性,包括它们作为通过传递生物货物进行细胞间通讯的介质的地位,以及它们报告的能够穿过阻碍许多递送系统的生物屏障的能力。然而,将基于 EV 的治疗方法转化和广泛应用存在许多挑战。其中一个尚未得到广泛研究的挑战涉及 EV 的保存和储存,这是实现超越资源密集型环境使用治疗性 EV 的必要条件。迄今为止的研究表明,最有前途的储存方式是 -80°C;然而,对储存介导效应的理解仍然有限。此外,储存的影响似乎因样本来源而异。对 EV 储存的知识和标准化的缺乏可能最终会阻碍其广泛的临床转化。本综述报告了 EV 保存和储存稳定性领域的最新知识,并强调了该领域未来的发展方向,这对最终开发 EV 疗法至关重要。